NuCana (FRA:N04) Short-Term Capital Lease Obligation : €0.09 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is NuCana Short-Term Capital Lease Obligation?

NuCana's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was €0.09 Mil.

NuCana's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 (€0.10 Mil) to Dec. 2024 (€0.09 Mil) but then stayed the same from Dec. 2024 (€0.09 Mil) to Mar. 2025 (€0.09 Mil).

NuCana's annual Short-Term Capital Lease Obligation declined from Dec. 2022 (€0.28 Mil) to Dec. 2023 (€0.24 Mil) and declined from Dec. 2023 (€0.24 Mil) to Dec. 2024 (€0.09 Mil).

NuCana Short-Term Capital Lease Obligation Historical Data

The historical data trend for NuCana's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuCana Short-Term Capital Lease Obligation Chart

NuCana Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.31

0.24

0.28

0.24

0.09

NuCana Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.20	0.15	0.10	0.09	0.09

NuCana Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

NuCana Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of NuCana's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

NuCana Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (FRA:N04) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

NCNA:USA N04:Germany

Address

3 Lochside Way, Edinburgh, GBR, EH12 9DT

Website

https://www.nucana.com

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

NuCana Headlines

No Headlines